Clinical Trials Directory

Trials / Completed

CompletedNCT02803268

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Tanabe Pharma Corporation · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Conditions

Interventions

TypeNameDescription
DRUGMT-8554 low dose
DRUGMT-8554 middle dose
DRUGMT-8554 high dose
DRUGPlacebo

Timeline

Start date
2016-06-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2016-06-16
Last updated
2025-12-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02803268. Inclusion in this directory is not an endorsement.

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Exp (NCT02803268) · Clinical Trials Directory